Viral warfare: unleashing engineered oncolytic viruses to outsmart cancer’s defenses is a research paper published in Frontiers in Immunology (2025). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R15 CA290568
National Institutes of Health
Grant: 1R15CA290568-01
Harnessing the potential of pharmacological small molecules to amplify VSV-based oncolytic viral therapy
National Institutes of Health
Grant: 7K01CA234324-04
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
National Institutes of Health
Grant: 5P20GM135000-02
Center for Pre-Clinical Cancer Research
National Institutes of Health
Grant: 1P20GM134974-01A1
Center for Applied Immunology and Pathological Processes
National Institutes of Health
Grant: 3P20GM103424-19S1
Louisiana Biomedical Research Network (LBRN)
National Institutes of Health
Grant: 5P30GM110760-02
GeneLab Core
National Institutes of Health
Grant: 1DP2CA301099-01
Novel Strategies to Enhance Drug Delivery and Tumor Immunogenicity in Pancreatic Cancer
FWCI
13.39
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords